Reaction Details |
| Report a problem with these data |
Target | D(3) dopamine receptor |
---|
Ligand | BDBM50219103 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_445357 (CHEMBL894567) |
---|
Ki | 0.4±n/a nM |
---|
Citation | Grundt, P; Prevatt, KM; Cao, J; Taylor, M; Floresca, CZ; Choi, JK; Jenkins, BG; Luedtke, RR; Newman, AH Heterocyclic analogues of N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)arylcarboxamides with functionalized linking chains as novel dopamine D3 receptor ligands: potential substance abuse therapeutic agents. J Med Chem50:4135-46 (2007) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
D(3) dopamine receptor |
---|
Name: | D(3) dopamine receptor |
Synonyms: | DOPAMINE D3 | DRD3 | DRD3_HUMAN | Dopamine D3 receptor | Dopamine D3 receptor (D3) | Dopamine D3 receptor (D3R) | Dopamine receptor | Dopamine receptor (D3) | Dopamine receptor D3 |
Type: | n/a |
Mol. Mass.: | 44243.43 |
Organism: | Homo sapiens (Human) |
Description: | n/a |
Residue: | 400 |
Sequence: | MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERAL
QTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILN
LCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTV
CSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQ
QTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRK
LSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHV
SPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC
|
|
|
BDBM50219103 |
---|
n/a |
---|
Name | BDBM50219103 |
Synonyms: | CHEMBL241973 | N-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-4-pyridin-2-ylbenzamide |
Type | Small organic molecule |
Emp. Form. | C27H32N4O2 |
Mol. Mass. | 444.5686 |
SMILES | COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(cc2)-c2ccccn2)CC1 |
Structure |
|